Our Team

Dr. Salem H. D. Al-Shemmari is a hematologist oncologist dedicated to advancing patient care in hematological and other malignancies through clinical practice, teaching, and research. He graduated from Kuwait University with a B.M.B.CH. degree and became a fellow of the Royal College of Physicians of Canada in Hemato-Oncology in 1994. He further specialized in Hematopoietic Stem Cell Transplantation at the Fred Hutchinson Cancer Research Center in Seattle in 1995. Dr. Salem serves as academic staff in the Department of Medicine, Kuwait University, teaching at both undergraduate and postgraduate levels. He established the Medical Oncology Fellowship Program and contributed to the Hematopathology and Hematology Fellowship Programs. He has established the myeloid neoplasm reference Lab at Kuwait Cancer Center. He is also a member of the Department of Hematology, Kuwait Cancer Center. Dr. Salem has authored over 60 peer-reviewed research papers, numerous review articles, technical reports, and laboratory manuals. He has led more than 10 peer-reviewed research grants, serving as principal investigator on 8. Author of a textbook titled ‘Basis of Malignant Hematology Practice in Kuwait: Emphasis on Local Data

Dr. Mohammad Soliman Ebraheem is a malignant hematologist at the Kuwait Cancer Control Center with a special interest in plasma cell neoplasms. He completed his internal medicine and hematology residencies at McMaster University in Canada, followed by an advanced fellowship in multiple myeloma, amyloidosis, and dysproteinemias at Mayo Clinic Rochester. He also holds a Master’s degree in Health Research Methodology from McMaster University, with a focus on evidence-based medicine.

Dr. Nourah M. Alsheridah, MPH, PhD is the Lead Epidemiologist and Data Scientist of Kuwait Centre for Disease Prevention and Control (K-CDC), Kuwait Ministry of Health. Dr. Alsheridah is involved in evaluation of screening programs and assessing their contribution to early diagnosis and better prognosis. She pursued her MPH in Epidemiology and Biostatistics from Kuwait University and earned her PhD in Epidemiology and Population Health focusing on Cancer Epidemiology from London School of Hygiene & Tropical Medicine (LSHTM) in 2025 and is currently an Honorary Research Fellow of Inequalities in Cancer Outcomes Network (ICON) at LSHTM. The topic of her doctoral thesis was “Breast Cancer Screening and Impact on Cancer Outcomes in Kuwait.” She specializes in research involving cancer and cancer genomic epidemiology, prevention of non-communicable diseases, causal inference and machine learning in health care data. Currently, she serves as a Co-Investigator in the lung cancer screening pilot study ALIA Kuwait (Aware Lung Initiative Advancement), which is supported by KFAS and is being conducted under leadership of Dr. Sulaiman Khadadah (Chest Hospital). She is Principal Investigator on the new study ‘From Screening to Survival in Kuwait: Breast Cancer Treatment Effectiveness, Genomic Epidemiology and Demographic Disparities, 2014–2026,’ with a KFAS grant submitted and Ministry of Health ethical approval pending.

Ahmed El-Sheashaey is the Chief Hospital Oncology Pharmacist and Medication Safety Officer at KCCC. Since joining in 2008, he has led major initiatives in chemotherapy and immunotherapy protocol development, hospital safety leadership, and multidisciplinary cancer care. He holds certifications in patient safety, sterile compounding, medication safety, and specialty pharmacy in oncology and hematology. As Staff Development Officer since 2012, he oversees pharmacist training and clinical competency development. Ahmed also contributes to research, abstracts, and pharmacoeconomics, and plays a leading role in establishing Kuwait’s first clinical and specialty oncology pharmacy service—supporting the transition to KCCC’s new, future-ready facility.

Dr. Mosaab Agrof serves as a Research Assistant at the Department of Medicine, Health Sciences Center, Kuwait University, collaborating with the team at the Kuwait Cancer Control Center. His work focuses on clinical data analysis, healthcare quality improvement, and the application of artificial intelligence tools to support medical research and oncology-related studies.